Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
U.S. stock index futures rose on Friday as Pfizer said it could apply for emergency use of its COVID-19 vaccine candidate as early as November, shaking off worries over a stand-off in Washington on more fiscal aid. .N
At 6:58 a.m. ET, Dow e-minis 1YMc1 were up 0.16% at 28,430. S&P 500 e-minis ESc1 were up 0.12% at 3,479.75, while Nasdaq 100 e-minis NQc1 were up 0.17% at 11,894. The top three NYSE percentage gainers premarket .PRPG.NQ: ** CIT Group Inc <CIT.N>, up 19.0% ** Navistar International Corp <NAV.N>, up 12.6% ** Nautilus Inc <NLS.N>, up 10.4% The top three NYSE percentage losers premarket .PRPL.NQ: ** SOS Limited <SOS.N>, down 9.9% ** Borr Drillng Ltd <BORR.N>, down 9.2% ** J Jill Inc <JILL.N>, down 6.3% The top three Nasdaq percentage gainers premarket .PRPG.O: ** ASLAN Pharmaceuticals Limited <ASLN.O>, up 85.9% ** Rewalk Robotics Ltd <RWLK.O>, up 35.3% ** Orchard Therapeutics Plc <ORTX.O>, up 35.7% The top three Nasdaq percentage losers premarket .PRPL.O: ** Biomerica Inc <BMRA.O>, down 17.8% ** China HGS Real Estate Inc <HGSH.O>, down 14.3% ** Medalist Diversified Reit Inc <MDRR.O>, down 13.2% ** Gilead GILD.O: down 1.3% premarket BUZZ- Dips as WHO study raises doubts on remdesivir's benefits against COVID-19 ** Yandex N.V YNDX.O: down 2.0% premarket BUZZ-Russia's Yandex terminates Tinkoff buyout talks, shares down ** MMTEC Inc MTC.O: up 26.5% premarket BUZZ- Rises on strong half-year revenue ** Snap SNAP.N: up 0.9% premarket BUZZ- Set to extend gains for 4th day after analysts hike PT ahead of results ** Amarin AMRN.O: up 5.9% premarket BUZZ- Rises on positive data from heart drug study ** Chewy Inc CHWY.N: up 3.7% premarket BUZZ- Gains as Jefferies upgrades to 'buy' ** Pfizer Inc PFE.N: up 1.2% premarket ** BioNTech SE BNTX.O: up 2.8% premarket BUZZ-Pfizer seeks U.S. emergency use nod for COVID-19 vaccine in November, shares rise
(Compiled by Dania Nadeem in Bengaluru)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.